Jump Financial’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-221,913
| Closed | -$1.01M | – | 1740 |
|
|
2024
Q1 | $1.01M | Sell |
221,913
-25,684
| -10% | -$116K | 0.03% | 801 |
|
|
2023
Q4 | $1.41M | Sell |
247,597
-26,905
| -10% | -$154K | 0.05% | 528 |
|
|
2023
Q3 | $1.26M | Sell |
274,502
-107,124
| -28% | -$493K | 0.05% | 560 |
|
|
2023
Q2 | $2.47M | Buy |
381,626
+289,626
| +315% | +$1.87M | 0.09% | 314 |
|
|
2023
Q1 | $694K | Buy |
+92,000
| New | +$694K | 0.03% | 757 |
|
|
2022
Q4 | – | Sell |
-230,400
| Closed | -$2.28M | – | 1518 |
|
|
2022
Q3 | $2.28M | Sell |
230,400
-42,212
| -15% | -$418K | 0.09% | 339 |
|
|
2022
Q2 | $2.9M | Buy |
272,612
+23,712
| +10% | +$253K | 0.12% | 222 |
|
|
2022
Q1 | $2.43M | Buy |
248,900
+194,800
| +360% | +$1.9M | 0.1% | 240 |
|
|
2021
Q4 | $774K | Buy |
54,100
+13,553
| +33% | +$194K | 0.05% | 481 |
|
|
2021
Q3 | $813K | Sell |
40,547
-76,253
| -65% | -$1.53M | 0.06% | 345 |
|
|
2021
Q2 | $2.57M | Buy |
+116,800
| New | +$2.57M | 0.25% | 69 |
|